MiRNA targeting (miR-577) of E2F3 was found to inhibit gastric cancer cell progression [59], and miRNA targeting of E2F3 and CCND1 (miR-449b) was found to inhibit the proliferation of SW1116 colon cancer stem cells [60]. Here, E2F3 is linked to colonic neoplasm.